The pediatric patient and upper respiratory infections

Tom Elwood1, Katherine Bailey

  • 1Department of Anesthesiology and Pain Medicine, Children's Hospital and Regional Medical Center, Seattle, WA 98105-0317, USA. tomelwood@hotmail.com

Insights

Children with active upper respiratory infections undergoing elective surgery face increased risks. Clinician decisions on cancelling surgery vary, highlighting the need for standardized risk assessment and further research into managing respiratory illness during pediatric surgery.

Area of Science:

  • Pediatric Anesthesiology
  • Respiratory Medicine
  • Surgical Risk Assessment

Background:

  • Children often require elective surgery with active or recent upper respiratory infections (URIs).
  • Increased respiratory adverse events are noted in this patient population.
  • Current thresholds for surgical cancellation due to URIs lack clinical consistency.

Purpose of the Study:

  • To review factors influencing decisions to proceed with or cancel elective surgery in children with URIs.
  • To identify areas where more data are needed regarding surgical risks and management strategies.
  • To explore potential therapies for reducing adverse events in this setting.

Main Methods:

  • Literature review and clinical consensus discussion on risk factors.
  • Analysis of variables such as respiratory secretions, pulmonary disease, intubation needs, and surgical site.
  • Identification of knowledge gaps concerning perioperative outcomes.

Main Results:

  • Surgical cancellation decisions are influenced by URI severity, patient comorbidities, airway management needs, and surgical location.
  • Significant variability exists among clinicians regarding acceptable risk thresholds.
  • Limited data exist on the precise risks of proceeding with surgery and the efficacy of interventions.

Conclusions:

  • Standardized guidelines are needed for managing pediatric elective surgery in the context of URIs.
  • Further research is crucial to quantify risks and evaluate therapies like lidocaine for managing laryngospasm in affected children.

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...